Age-related macular degeneration is a chronic eye disease in which the part of your eye responsible for central vision — your macula (MAK-u-luh) — gradually deteriorates, causing blurred central vision or a blind spot in the center of your visual field. Macular degeneration tends to affect adults age 50 and older.
Wet macular degeneration occurs when new blood vessels grow and leak fluid underneath the macula, an area of densely packed light-sensitive cells in the central part of the retina. Most cases of wet macular degeneration develop from the dry type of macular degeneration.
Early detection and treatment of wet macular degeneration may help reduce the extent of vision loss and in some instances improve vision.
With wet macular degeneration, the following signs and symptoms may appear and progress rapidly:
Your vision may falter in one eye, while the other remains fine for years. You may not notice any changes or only mild changes because your good eye compensates for the eye with macular degeneration. Your vision and lifestyle are dramatically affected when this condition develops in both eyes.
When to see a doctor
See your eye doctor — particularly after age 50 — if:
One way to monitor your eyes to determine if you may need to visit your eye doctor is to check your vision regularly using an Amsler grid. This simple test may help you detect changes in your sight that you otherwise may not notice.
Here's what you do:
Amsler grid (PDF file requiring Adobe Reader)
Wet macular degeneration develops when abnormal new blood vessels grow from the choroid — the layer of blood vessels sandwiched between the retina and the outer, firm coat of the eye called the sclera — under and into the macular portion of the retina (a process known as choroidal neovascularization). These abnormal vessels leak fluid or blood, which is why this form of macular degeneration is called "wet." Fluid or blood between the choroid and macula interferes with the retina's function and causes your central vision to blur. In addition, what you see when you look straight ahead becomes wavy or crooked, and blank spots block out part of your field of vision.
Eyes with the wet form of macular degeneration almost always show signs of the dry form — yellow fat-like deposits (drusen) and mottled pigmentation of the retina.
The wet form accounts for about 15 percent of all cases, but it's responsible for most of the severe vision loss that people with macular degeneration experience. If you develop wet macular degeneration in one eye, your odds of getting it in the other eye increase greatly.
Much like the dry form of macular degeneration, the wet form may be caused by a breakdown in the eye's waste-removal system. The light-sensitive cells in the retina called cones and rods produce waste. If this waste accumulates, it interrupts the retina's nutrient supply, and retinal tissue deteriorates. Whether this is the mechanism that triggers the growth of abnormal blood vessels is unclear, and it remains the subject of scientific study.
With the wet form of macular degeneration, sight loss is usually severe and rapid, often deteriorating to 20/200 vision or worse, occurring within weeks or months. When vision is 20/200 or worse in both eyes, you're considered legally blind.
Retinal pigment epithelial detachment
Another form of wet macular degeneration, called retinal pigment epithelial detachment, occurs when fluid leaks from the choroid and collects between the choroid and the next-deeper cell layer, the retinal pigment epithelium (RPE). No abnormal choroidal blood vessel growth is apparent when the RPE is detached. Instead, fluid beneath the RPE causes what looks like a blister or a bump under the macula.
Although this kind of macular degeneration causes symptoms similar to those of typical wet macular degeneration, your vision can remain relatively stable for many months or even years before it deteriorates. Eventually, however, RPE detachment tends to evolve to the more common wet form of macular degeneration associated with the development of newly growing abnormal choroidal blood vessels.
Researchers don't know the exact causes of macular degeneration, but they have identified some contributing factors, including:
To check for macular degeneration, a dilated eye exam is necessary. Make an appointment with a doctor who specializes in eye care — an optometrist or an ophthalmologist — who can evaluate your condition and perform a complete eye exam.
What you can do
Appointments can be brief. Make the best use of that limited time by preparing beforehand.
Questions to ask your eye doctor
Questions your eye doctor may ask
Diagnostic tests for macular degeneration may include:
An eye examination. One of the things your eye doctor looks for while examining the inside of your eye is the presence of drusen and mottled pigmentation in the macula. The eye examination includes a simple test of your central vision and may include testing with an Amsler grid. If you have macular degeneration, when you look at the grid some of the straight lines may seem faded, broken or distorted. By noting where the break or distortion occurs — usually on or near the center of the grid — your eye doctor can better determine the location and extent of your macular damage.
Regular screening eye examinations can detect early signs of macular degeneration before the disease leads to vision loss.
Angiography. To evaluate the extent of the damage from macular degeneration, your eye doctor may use fluorescein angiography. In this procedure, fluorescein dye is injected into a vein in your arm and photographs are taken of the back of the eye as the dye passes through blood vessels in your retina and choroid. Your doctor then uses these photographs to detect changes in macular pigmentation or to identify small macular blood vessels.
Your doctor may also suggest a similar procedure called indocyanine green angiography. Instead of fluorescein, a dye called indocyanine green is used. This test provides information that complements the findings obtained through fluorescein angiography.
Treatment of wet macular degeneration focuses on stopping further progression of the disease.
Wet macular degeneration treatments include:
Laser therapy (photocoagulation). In this treatment, your doctor uses a high-energy laser beam to destroy abnormal, leaky blood vessels — known as choroidal neovascularizations (CNVs) — under the macula. The procedure is used to prevent further damage to the macula and halt continued vision loss for as long as possible.
Laser therapy has major limitations as a treatment for wet macular degeneration. It generally isn't used if you have CNV directly under the center of the macula. Also, the more damaged your macula is, the lower the likelihood of success. Because of these restrictions, only a small percentage of people who have wet macular degeneration are good candidates for laser therapy.
Laser treatment won't replace any dark or gray spots that are already completely and permanently blank. With time, however, you may stop being aware of this spot, especially when you use both eyes. About half of those who seem likely to have a good result eventually need repeat laser surgery. However, repeat laser treatment isn't always an option.
If you closely monitor your vision and have frequent follow-ups with your doctor, you may retain more sight than if you go untreated.
Photodynamic therapy (PDT). This therapy is primarily used for treating CNV directly under the fovea. The fovea lies at the center of your macula and in healthy eyes provides your sharpest vision. If conventional hot-laser surgery were used at this location, it could destroy all or part of your central vision. PDT increases your chances of preserving some of that vision. It won't bring back any of the vision you have lost, but it may halt the loss of your vision or at least slow down the rate of vision loss.
This procedure combines a cold laser and a light-sensitizing drug called verteporfin (Visudyne) that's injected into your bloodstream. The drug concentrates in the CNV under the macula. When your doctor directs cold-laser light at the macula, the drug releases substances that theoretically can close off the abnormal blood vessels without damaging the macula, and the CNV transforms into a thin scar.
The overlying rods and cones are largely preserved, so there's a better chance that you'll preserve some of your vision with this procedure than if you had hot-laser surgery or no treatment at all. The therapy can be repeated if the CNV doesn't close or if it reopens after initial closure. After the procedure, you'll need to avoid direct sunlight and intensely bright lights until the drug wears off, about five days after treatment.
Vascular endothelial growth factor antagonists (anti-VEGF medications). These drugs help stop growth (proliferation) of new CNV by blocking the effects of a growth factor these blood vessels need to thrive. These drugs are commonly used and are among the most effective therapies for treating wet macular degeneration.
Pegaptanib (Macugen), one early anti-VEGF medication, stops the formation of new blood vessels and decreases leakage from existing blood vessels. However, other more recent and more effective anti-VEGF medications have largely replaced Macugen. These include ranibizumab and bevacizumab.
Both ranibizumab (Lucentis) and bevacizumab (Avastin) — a colon and rectal cancer treatment drug that's closely related to ranibizumab — stop fluid leakage from CNV. In some instances, you may partially recover vision as the blood vessels shrink and the fluid under the retina absorbs, allowing retinal cells to regain some function. Other anti-VEGF medications are currently being studied, but they're not yet available for clinical use.
Anti-VEGF medications are injected directly into your eye. You may need repeat injections every four weeks to maintain the beneficial effect of the medication. Researchers are investigating whether anti-VEGF medications might prove more effective when used in combination with other therapies, such as PDT or injections of steroid drugs (glucocorticoids). Also being investigated is the optimal timing of the intervals between injections of anti-VEGF medications.
Because research into new treatments for macular degeneration is ongoing, it's a good idea to visit your doctor periodically to see if a new treatment might be available.
Macular degeneration doesn't affect your side (peripheral) vision and usually doesn't cause total blindness. But it can rob you of your central vision — which is important for driving, reading and recognizing people's faces. A low-vision center may be able to assess your visual capabilities and suggest certain optical and household devices that can be helpful for some near-vision tasks. Ask your eye doctor if there are any low-vision centers in your area.
There are ways to cope with impaired vision. Below are a few suggestions:
Some people have turned to complementary or alternative therapies, such as bilberry, ginkgo and shark cartilage, in the belief that they can help prevent the progression of macular degeneration.
However, there's no conclusive evidence that any of these products are effective for macular degeneration, and some may interact with other medications you're taking. Check with your doctor before taking any dietary or herbal supplement.
The following measures may help you avoid macular degeneration:
If you have some vision loss because of macular degeneration, your eye doctor can prescribe optical devices called low-vision aids that will help you see better for close-up work. Or your doctor may refer you to a low-vision specialist. In addition, a wide variety of support services and rehabilitation programs are available that may help you adjust your lifestyle.